The leader of #TissueCytometer, digitization slide in BF/IF/Spectral, AI-based quantitative image analysis by FACS-Like scatter plots. Follow us for updates!
📢#OpenForSubmissions
'Advancements in Precision Medicine: Cancer Organoid Co-Culture Models for Enhanced Cancer Research and Modelling'
Edited by Uwe Ritter, Rupert Ecker and Talita Glaser
Coordinated by Achala Vintharanage
Find out more➡️https://t.co/mQ6IBz9Gi7
Based in Austria, @TissueGnostics is an innovative #MedTech & leading global provider of cutting-edge tissue cytometers. Through one of our #REDI Fellowships, the company was so impressed with the calibre of AUS research it opened a subsidiary down under. https://t.co/hqBdLWu5H6
Thank you to 2023 QIMR Student Symposium Gold Sponsor @TissueGnostics!!!
TissueGnostics provides streamlined solutions for biomedical imaging + image analysis, some of which is already supporting QIMR researchers.
Check them out: https://t.co/2R5HhbTV0j
@students_qimr
What is Multiplexing & How does it Work?
#Multiplexing combines multiple measurements in a single experiment. In tissue cytometry, multiplexing involves using multiple fluorophores that emit at different wavelengths or even...
Read more here: https://t.co/64OY9vGGxR
Checkpoint Molecule Panel Predicts Response to the Immunotherapy in Liver Cancer
Heij et al. investigated the expression of checkpoint molecules in the tumor microenvironment of intrahepatic cholangiocarcinoma. They found that...
Read further: https://t.co/YahIF638cT
20 Years of TG – More than 2300 Publications
This year TissueGnostics is celebrating its 20-year anniversary! We are happy to announce that TG‘s tissue cytometry solutions are being used for high-impact research worldwide.
Read more: https://t.co/YabnGiyqPr
Beyond Genetics: Exploring the Role of Epigenetic Modification in Chronic Lymphocytic Leukemia
In chronic lymphocytic leukemia (CLL), research has shown that epigenetic changes are a major determinant of the different...
Click here to read more: https://t.co/zilm2iO5n4
The IHC Necrotic Tumor Angio App can segment #tumor tissues into tumor, necrotic tissue, and blood vessels using the AI #Classifier. It outputs...
Click to read more: https://t.co/08zQZsx8B1
AI-based Analysis of ‘Anti-/Pro-Tumor’ Profiles for Pancreatic Adenocarcinoma
To predict the survival of patients with pancreatic adenocarcinoma, Zhou et al...
To read more, click here: https://t.co/25arIwGkPp
#cancer#ai#imageanalysis
The IHC Necrotic Tumor Angio App can segment #tumor tissues into tumor, necrotic tissue, and blood vessels using the AI #Classifier. It outputs the area of tumor, necrotic tissue, and blood vessels, as well as the number and percentage of blood vessels.
https://t.co/htj015gcor
As a part of #20yearsTG celebration, we continue to talk with our colleagues about working at TissueGnostics. This time we introduce you to Felix Tsai - Asia-Pacific Regional Business Manager.
To hear more from Felix, head to our LinkedIn:
https://t.co/WIbAap3ZKT
Case Study: Evaluating the Distance of Tumor Cells from Blood Vessels using the IF Tumor Foci Angio App.
Discover more: https://t.co/HgcWsXPsxH
#vascular#tumor